These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Radiofrequency ablation for the treatment of stage I non-small cell lung cancer in high-risk patients. Pennathur A; Luketich JD; Abbas G; Chen M; Fernando HC; Gooding WE; Schuchert MJ; Gilbert S; Christie NA; Landreneau RJ J Thorac Cardiovasc Surg; 2007 Oct; 134(4):857-64. PubMed ID: 17903496 [TBL] [Abstract][Full Text] [Related]
3. Pulmonary radiofrequency ablation: long-term safety and efficacy in 153 patients. Simon CJ; Dupuy DE; DiPetrillo TA; Safran HP; Grieco CA; Ng T; Mayo-Smith WW Radiology; 2007 Apr; 243(1):268-75. PubMed ID: 17392258 [TBL] [Abstract][Full Text] [Related]
4. Survival of patients with true pathologic stage I non-small cell lung cancer. Cerfolio RJ; Bryant AS Ann Thorac Surg; 2009 Sep; 88(3):917-22; discussion 922-3. PubMed ID: 19699920 [TBL] [Abstract][Full Text] [Related]
5. Radiofrequency ablation of non-small-cell carcinoma of the lung under real-time FDG PET CT guidance. Schoellnast H; Larson SM; Nehmeh SA; Carrasquillo JA; Thornton RH; Solomon SB Cardiovasc Intervent Radiol; 2011 Feb; 34 Suppl 2():S182-5. PubMed ID: 20508937 [TBL] [Abstract][Full Text] [Related]
6. Preoperative intrathoracic lymph node staging in patients with non-small-cell lung cancer: accuracy of integrated positron emission tomography and computed tomography. Billé A; Pelosi E; Skanjeti A; Arena V; Errico L; Borasio P; Mancini M; Ardissone F Eur J Cardiothorac Surg; 2009 Sep; 36(3):440-5. PubMed ID: 19464906 [TBL] [Abstract][Full Text] [Related]
7. Carcinoembryonic antigen level in serum and pleural lavage fluid in non-small cell lung cancer. Tomita M; Shimizu T; Ayabe T; Yonei A; Onitsuka T Thorac Cardiovasc Surg; 2010 Sep; 58(6):350-3. PubMed ID: 20824588 [TBL] [Abstract][Full Text] [Related]
8. Comparison of survival after sublobar resections and ablative therapies for stage I non-small cell lung cancer. Zemlyak A; Moore WH; Bilfinger TV J Am Coll Surg; 2010 Jul; 211(1):68-72. PubMed ID: 20610251 [TBL] [Abstract][Full Text] [Related]
9. Radiofrequency ablation for the treatment of non-small cell lung cancer in marginal surgical candidates. Fernando HC; De Hoyos A; Landreneau RJ; Gilbert S; Gooding WE; Buenaventura PO; Christie NA; Belani C; Luketich JD J Thorac Cardiovasc Surg; 2005 Mar; 129(3):639-44. PubMed ID: 15746749 [TBL] [Abstract][Full Text] [Related]
10. Prognostic evaluation of nodal staging based on the new IASLC lymph node map for lung cancer. Takamochi K; Oh S; Suzuki K Thorac Cardiovasc Surg; 2010 Sep; 58(6):345-9. PubMed ID: 20824587 [TBL] [Abstract][Full Text] [Related]
11. Cost and effectiveness of radiofrequency ablation versus limited surgical resection for stage I non-small-cell lung cancer in elderly patients: is less more? Alexander ES; Machan JT; Ng T; Breen LD; DiPetrillo TA; Dupuy DE J Vasc Interv Radiol; 2013 Apr; 24(4):476-82. PubMed ID: 23462066 [TBL] [Abstract][Full Text] [Related]
12. Percutaneous CT-guided radiofrequency ablation as supplemental therapy after systemic chemotherapy for selected advanced non-small cell lung cancers. Li X; Zhao M; Wang J; Fan W; Li W; Pan T; Wu P AJR Am J Roentgenol; 2013 Dec; 201(6):1362-7. PubMed ID: 24261378 [TBL] [Abstract][Full Text] [Related]
13. Radiofrequency ablation for treatment of medically inoperable stage I non-small cell lung cancer. Lanuti M; Sharma A; Digumarthy SR; Wright CD; Donahue DM; Wain JC; Mathisen DJ; Shepard JA J Thorac Cardiovasc Surg; 2009 Jan; 137(1):160-6. PubMed ID: 19154919 [TBL] [Abstract][Full Text] [Related]
15. Salvage lung resection after definitive radiation (>59 Gy) for non-small cell lung cancer: surgical and oncologic outcomes. Bauman JE; Mulligan MS; Martins RG; Kurland BF; Eaton KD; Wood DE Ann Thorac Surg; 2008 Nov; 86(5):1632-8; discussion 1638-9. PubMed ID: 19049763 [TBL] [Abstract][Full Text] [Related]
16. [Comparison between PET(-FDG) and computed tomography in the staging of lung cancer. Consequences for operability in 94 patients]. Prévost A; Papathanassiou D; Jovenin N; Menéroux B; Cuif-Job A; Bruna-Muraille C; Domange-Testard A; Liehn JC Rev Pneumol Clin; 2009 Dec; 65(6):341-9. PubMed ID: 19995654 [TBL] [Abstract][Full Text] [Related]
17. [Lung neoplasms--ultrasonic endoscopy as a first diagnostic tool]. Pneumologie; 2008 Apr; 62(4):188. PubMed ID: 18393179 [No Abstract] [Full Text] [Related]
18. Lung cancer and radiofrequency ablation. Rose SC; Thistlethwaite PA; Sewell PE; Vance RB J Vasc Interv Radiol; 2006 Jun; 17(6):927-51; quiz 951. PubMed ID: 16778226 [TBL] [Abstract][Full Text] [Related]
19. Fluorodeoxyglucose uptake of primary non-small cell lung cancer at positron emission tomography: new contrary data on prognostic role. Vesselle H; Freeman JD; Wiens L; Stern J; Nguyen HQ; Hawes SE; Bastian P; Salskov A; Vallières E; Wood DE Clin Cancer Res; 2007 Jun; 13(11):3255-63. PubMed ID: 17545531 [TBL] [Abstract][Full Text] [Related]
20. [Clinical analysis of operation combined chemotherapy for stage IIIa non-small cell lung cancer]. Wang W; Li H; Shang LQ; Li XC; Li J; Song WA; Wen F Zhonghua Wai Ke Za Zhi; 2005 Nov; 43(22):1450-2. PubMed ID: 16318812 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]